Plymouth Meeting, PA – November 19, 2015: CRF Health, the leading global provider of electronic Clinical Outcome Assessment (eCOA) solutions for the life sciences industry, will be attending the JP Morgan 34th Annual Healthcare Conference in San Francisco, January 11-14th 2016.
eCOA continues to experience year-on-year growth, with emerging technologies delivering on long-term expectations by creating value in the development of new treatments. CRF Health's CEO, Rachael Wyllie, will be meeting with pharmaceutical, biotechnology and medical device companies at the conference to discuss how they too can realize the benefits of an electronic approach to this type of data collection. Delegates will take away expert insight on how their trials can achieve high levels of patient compliance, early visibility into patient perceptions and fast database lock.
About CRF Health
CRF Health is the leading provider of electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials. With experience in more than 650 trials, over 100 languages and across 74 countries, CRF Health’s TrialMax eCOA solutions consistently demonstrate the industry’s highest data accuracy, patient and site compliance, and patient retention.
CRF Health’s TrialMax eCOA solutions improve trial engagement by fitting into the lives of patients and seamlessly integrating into sites to maximize protocol compliance. Their eCOA solutions include PROs (Patient Reported Outcomes), ObsROs (Observer Reported Outcomes) and ClinROs (Clinician or Rater Reported Outcomes).
Contact: email@example.com, +1 267.498.2350
About the Author
Associate Director of Marketing at CRF HealthMore Content by Heather Bilinski